BACKGROUND: The diagnosis and staging of hilar cholangiocarcinoma (HCCA) remain challenging despite recent advances in imaging. Little is known about the use of positron emission tomography/computed tomography (PET/CT) in HCCA. OBJECTIVES: This study aimed to evaluate the additional value of FDG-PET/CT and standardized uptake value (SUV) in patients with highly suspected HCCA. METHODS: Between February 2006 and August 2009, PET/CT was performed in 30 patients with highly suspected HCCA, all of whom were deemed resectable by conventional staging methods, including laparoscopy. The results of PET-CT and SUV were compared with intraoperative and histopathological findings. RESULTS: The primary tumour was (18) F-FDG-positive in 88% of patients. Sensitivity and specificity for the detection of regional lymph node metastases and distant metastases were 67% and 68%, and 33% and 96%, respectively. The median SUV in the primary tumour was significantly (P < 0.05) higher in patients with (mean: 8.9) than without (mean: 6.1) distant metastases. The SUV in patients with benign disease (n= 4) showed a trend towards lower values than in patients with cholangiocarcinoma, although this was not significant. CONCLUSIONS: After conventional staging including diagnostic laparoscopy, the additional value of PET/CT is limited. This somewhat disappointing finding may reflect the fact that extensive staging studies were carried out prior to PET/CT. The SUV potentially predicts patients with distant metastases and may differentiate between HCCA and benign lesions that mimic malignancies.
BACKGROUND: The diagnosis and staging of hilar cholangiocarcinoma (HCCA) remain challenging despite recent advances in imaging. Little is known about the use of positron emission tomography/computed tomography (PET/CT) in HCCA. OBJECTIVES: This study aimed to evaluate the additional value of FDG-PET/CT and standardized uptake value (SUV) in patients with highly suspected HCCA. METHODS: Between February 2006 and August 2009, PET/CT was performed in 30 patients with highly suspected HCCA, all of whom were deemed resectable by conventional staging methods, including laparoscopy. The results of PET-CT and SUV were compared with intraoperative and histopathological findings. RESULTS: The primary tumour was (18) F-FDG-positive in 88% of patients. Sensitivity and specificity for the detection of regional lymph node metastases and distant metastases were 67% and 68%, and 33% and 96%, respectively. The median SUV in the primary tumour was significantly (P < 0.05) higher in patients with (mean: 8.9) than without (mean: 6.1) distant metastases. The SUV in patients with benign disease (n= 4) showed a trend towards lower values than in patients with cholangiocarcinoma, although this was not significant. CONCLUSIONS: After conventional staging including diagnostic laparoscopy, the additional value of PET/CT is limited. This somewhat disappointing finding may reflect the fact that extensive staging studies were carried out prior to PET/CT. The SUV potentially predicts patients with distant metastases and may differentiate between HCCA and benign lesions that mimic malignancies.
Authors: C Nanni; D Rubello; P Castellucci; M Farsad; R Franchi; S Toso; C Barile; L Rampin; O Nibale; S Fanti Journal: Eur J Nucl Med Mol Imaging Date: 2005-02-22 Impact factor: 9.236
Authors: M F Gerhards; D G Gonzalez; H ten Hoopen-Neumann; T M van Gulik; L T de Wit; D J Gouma Journal: Eur J Surg Oncol Date: 2000-08 Impact factor: 4.424
Authors: David J Rea; Manuel Munoz-Juarez; Michael B Farnell; John H Donohue; Florencia G Que; Brian Crownhart; Dirk Larson; David M Nagorney Journal: Arch Surg Date: 2004-05
Authors: Margo Shoup; Mithat Gonen; Michael D'Angelica; William R Jarnagin; Ronald P DeMatteo; Lawrence H Schwartz; Scott Tuorto; Leslie H Blumgart; Yuman Fong Journal: J Gastrointest Surg Date: 2003 Mar-Apr Impact factor: 3.452
Authors: Seung Won Lee; Hong Joo Kim; Jung Ho Park; Dong Il Park; Yong Kyun Cho; Chong Il Sohn; Woo Kyu Jeon; Byung Ik Kim Journal: J Gastroenterol Date: 2009-12-25 Impact factor: 7.527
Authors: Adam D Barlow; Guiseppe Garcea; David P Berry; Arumugam Rajesh; Roshni Patel; Matthew S Metcalfe; Ashley R Dennison Journal: Langenbecks Arch Surg Date: 2013-09-01 Impact factor: 3.445
Authors: Robert J S Coelen; Anthony T Ruys; Jimme K Wiggers; Chung Y Nio; Joanne Verheij; Dirk J Gouma; Marc G H Besselink; Olivier R C Busch; Thomas M van Gulik Journal: Ann Surg Oncol Date: 2016-09-01 Impact factor: 5.344
Authors: F Rassam; E Roos; K P van Lienden; J E van Hooft; H J Klümpen; G van Tienhoven; R J Bennink; M R Engelbrecht; A Schoorlemmer; U H W Beuers; J Verheij; M G Besselink; O R Busch; T M van Gulik Journal: Langenbecks Arch Surg Date: 2018-01-19 Impact factor: 3.445
Authors: Anthony T Ruys; Steven van Haelst; Olivier R Busch; Erik A Rauws; Dirk J Gouma; Thomas M van Gulik Journal: World J Surg Date: 2012-09 Impact factor: 3.352